Filing Details

Accession Number:
0000899243-18-019325
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-03 18:44:34
Reporting Period:
2018-07-02
Accepted Time:
2018-07-03 18:44:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1693415 Translate Bio Inc. TBIO Biological Products, (No Disgnostic Substances) (2836) 611807780
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1742519 Mrl Ventures Fund Llc One Merck Drive
Whitehouse Station NJ 08889
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-02 1,848,503 $0.00 1,848,503 No 4 C Direct
Common Stock Acquisiton 2018-07-02 25,000 $13.00 1,873,503 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2018-07-02 9,259,259 $0.00 1,666,683 $0.00
Common Stock Series C Preferred Stock Disposition 2018-07-02 1,010,101 $0.00 181,819 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The Series B and Series C Preferred Stock converted into Common Stock on a 5.5555-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.